Pharma Foods InternationalPharma Foods International Co., Ltd.2929東証プライム食料品FY ending Jul 2025, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending Jul 2021 | FY ending Jul 2022 | FY ending Jul 2023 | FY ending Jul 2024 | FY ending Jul 2025 |
|---|---|---|---|---|---|---|
| Bio Functional Seeds | — | 2,85227.0% | 8,07920.5% | — | — | — |
| Bio Direct Value | — | 43,52412.8% | 51,8861.2% | — | — | — |
| Bio Medical | +12.2%5y | 37521.6% | 220-105.0% | 343-81.0% | 478-56.9% | 331-114.2% |
| BtoB | +0.4%3y | — | 8,07920.5% | 8,41815.5% | 9,10817.3% | 8,18215.3% |
| BtoC | +3.0%3y | — | 51,8861.2% | 59,7886.3% | 52,54310.1% | 56,7306.5% |
| Other | -15.5%2y | — | — | 21-23.8% | 16-100.0% | 15-66.7% |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書－第28期(2024/08/01－2025/07/31)
EDINET (FSA Japan)
有価証券報告書－第27期(2023/08/01－2024/07/31)
EDINET (FSA Japan)
有価証券報告書－第26期(2022/08/01－2023/07/31)
EDINET (FSA Japan)
有価証券報告書－第25期(令和3年8月1日－令和4年7月31日)
EDINET (FSA Japan)
有価証券報告書－第24期(令和2年8月1日－令和3年7月31日)
EDINET (FSA Japan)
有価証券報告書－第23期(令和1年8月1日－令和2年7月31日)
Extracted from XBRL: 52 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.